184 related articles for article (PubMed ID: 7619017)
1. There is a pathologic relationship between ApoE-epsilon 4 and Alzheimer's disease.
Corder EH; Saunders AM; Pericak-Vance MA; Roses AD
Arch Neurol; 1995 Jul; 52(7):650-1. PubMed ID: 7619017
[No Abstract] [Full Text] [Related]
2. ApoE-epsilon 4 and early-onset Alzheimer's.
Okuizumi K; Onodera O; Tanaka H; Kobayashi H; Tsuji S; Takahashi H; Oyanagi K; Seki K; Tanaka M; Naruse S
Nat Genet; 1994 May; 7(1):10-1. PubMed ID: 8075630
[No Abstract] [Full Text] [Related]
3. Allele doses of apolipoprotein E type epsilon 4 in sporadic late-onset Alzheimer's disease.
Lucotte G; Aouizérate A; Gérard N; Turpin JC; Landais P
Am J Med Genet; 1995 Dec; 60(6):566-9. PubMed ID: 8825898
[TBL] [Abstract][Full Text] [Related]
4. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.
Corder EH; Saunders AM; Strittmatter WJ; Schmechel DE; Gaskell PC; Small GW; Roses AD; Haines JL; Pericak-Vance MA
Science; 1993 Aug; 261(5123):921-3. PubMed ID: 8346443
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein E-epsilon 4 allele and Alzheimer's disease.
Anwar N; Lovestone S; Cheetham ME; Levy R; Powell JF
Lancet; 1993 Nov; 342(8882):1308-9. PubMed ID: 7901622
[No Abstract] [Full Text] [Related]
6. Apolipoprotein E genotype and its effect on duration and severity of early and late onset Alzheimer's disease.
Norrman J; Brookes AJ; Yates C; St Clair D
Br J Psychiatry; 1995 Oct; 167(4):533-6. PubMed ID: 8829725
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E-epsilon 4 allele and Alzheimer's disease.
Czech C; Mönning V; Tienari PJ; Hartmann T; Masters C; Beyreuther K; Förstl H
Lancet; 1993 Nov; 342(8882):1309. PubMed ID: 7901624
[No Abstract] [Full Text] [Related]
8. Lack of an association between apolipoprotein E epsilon 4 and Alzheimer's disease in elderly Nigerians.
Osuntokun BO; Sahota A; Ogunniyi AO; Gureje O; Baiyewu O; Adeyinka A; Oluwole SO; Komolafe O; Hall KS; Unverzagt FW
Ann Neurol; 1995 Sep; 38(3):463-5. PubMed ID: 7668835
[TBL] [Abstract][Full Text] [Related]
9. [The apolipoprotein E gene and Alzheimer disease phenotype].
Kurz A; Egensperger R; Lautenschlager N; Haupt M; Altland K; Graeber MB; Müller U
Z Gerontol Geriatr; 1995; 28(3):195-9. PubMed ID: 7664194
[TBL] [Abstract][Full Text] [Related]
10. Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease.
Corder EH; Saunders AM; Strittmatter WJ; Schmechel DE; Gaskell PC; Rimmler JB; Locke PA; Conneally PM; Schmader KE; Tanzi RE
Neurology; 1995 Jul; 45(7):1323-8. PubMed ID: 7617191
[TBL] [Abstract][Full Text] [Related]
11. [Apolipoprotein E polymorphism and Alzheimer disease].
van der Weide J; Steijns LS; Teepen JL; Noback WJ; Klaverwijden G
Tijdschr Gerontol Geriatr; 1996 Apr; 27(2):73-7. PubMed ID: 8669075
[TBL] [Abstract][Full Text] [Related]
12. No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease.
Murphy GM; Taylor J; Kraemer HC; Yesavage J; Tinklenberg JR
Am J Psychiatry; 1997 May; 154(5):603-8. PubMed ID: 9137113
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease.
van Duijn CM; de Knijff P; Cruts M; Wehnert A; Havekes LM; Hofman A; Van Broeckhoven C
Nat Genet; 1994 May; 7(1):74-8. PubMed ID: 8075646
[TBL] [Abstract][Full Text] [Related]
14. Interactions of apolipoprotein E genotype, total cholesterol level, age, and sex in prediction of Alzheimer's disease: a case-control study.
Jarvik GP; Wijsman EM; Kukull WA; Schellenberg GD; Yu C; Larson EB
Neurology; 1995 Jun; 45(6):1092-6. PubMed ID: 7783869
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E epsilon 4 and the pattern of regional brain atrophy in Alzheimer's disease.
Hashimoto M; Yasuda M; Tanimukai S; Matsui M; Hirono N; Kazui H; Mori E
Neurology; 2001 Oct; 57(8):1461-6. PubMed ID: 11673590
[TBL] [Abstract][Full Text] [Related]
16. Influence of the apolipoprotein E genotype on amyloid deposition and neurofibrillary tangle formation in Alzheimer's disease.
Nagy Z; Esiri MM; Jobst KA; Johnston C; Litchfield S; Sim E; Smith AD
Neuroscience; 1995 Dec; 69(3):757-61. PubMed ID: 8596645
[TBL] [Abstract][Full Text] [Related]
17. Polygenic determinants of Alzheimer's disease: modulation of the risk by alpha-1-antichymotrypsin.
DeKosky ST; Aston CE; Kamboh MI
Ann N Y Acad Sci; 1996 Dec; 802():27-34. PubMed ID: 8993481
[TBL] [Abstract][Full Text] [Related]
18. Apolipoprotein E genotype and Alzheimer's disease.
Payami H; Kaye J; Heston LL; Bird TD; Schellenberg GD
Lancet; 1993 Sep; 342(8873):738. PubMed ID: 8103834
[No Abstract] [Full Text] [Related]
19. Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease.
Dal Forno G; Rasmusson DX; Brandt J; Carson KA; Brookmeyer R; Troncoso J; Kawas CH
Arch Neurol; 1996 Apr; 53(4):345-50. PubMed ID: 8929157
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E-epsilon 4 allele and Alzheimer's disease.
Amouyel P; Brousseau T; Fruchart JC; Dallongeville J
Lancet; 1993 Nov; 342(8882):1309. PubMed ID: 7901623
[No Abstract] [Full Text] [Related]
[Next] [New Search]
